Vaccines For Blood Pressure

Vaccines For Blood Pressure

What is the simplest definition of blood pressure?

Force exerted by circulating blood against the walls of arteries. Blood pressure is measured in two ways: diastolic (measured when the heart beats, when blood pressure is at its maximum) and diastolic (measured when the heart does not beat, when blood pressure is at its lowest) (measured between heart beats, when blood pressure is at its lowest).


A vaccine technique for such treatment of hypertension seems appealing, and there has been lots of research into this strategy over many decades, however attempts to apply this strategy to the management of hypertension have been ineffective. Immunisation versus components of the renin-angiotensin system has the potential to improve long-term therapy of hypertension because it does not necessitate everyday compliance with oral medications to be effective. A technique like this may also have therapeutic effects too far for glycemic control, such as better treatment and prevention of heart failure, as well as cardio – vascular, cerebrovascular, & renal disease. The efficacy and safety of this method, however, are being questioned, despite the apparent benefits. When administered to animal models of hypertension, renin vaccination was found to be helpful in lowering blood pressure, but it was also associated with kidney autoimmune disease. There are also theoretical arguments that angiotensin-converting enzyme (ACE) immunisation has limited effectiveness, and clinical studies have confirmed these concerns. Another potential treatment option is vaccination against the angiotensin Receptor type 1 receptor, which has not yet been subjected to clinical trials in humans. As a result, the relevance of immunisation against components of the renin-angiotensin system in the management of hypertension has yet to be determined.

It is possible that a vaccine against high blood pressure is in development

In Japan, scientists are working on producing a vaccination that could one day replace the daily pill that individuals use to treat hypertension.

According to research released recently to Hypertension Trusted Sources, the journal of the American Heart Association, scientists in Japan are working on developing a vaccine that, in the future, may be able to decrease blood pressure for up to six months after administration.

Long-term research with rats has come to an end, according to the researchers, and they believe it could develop into a breakthrough therapy for people with hypertension that is less expensive than taking a daily tablet.

The study’s co-author, Dr. Hironori Nakagami, Ph.D., a professor at Japan’s Osaka University, said, “The ability of a vaccine for hypertension offers an innovative treatment that could be very effective in the management of non-compliance, which is one of the major problems in the management of hypertensive patients.”

According to the findings of the Osaka study, the researchers utilised needleless injections to inoculate hypertensive rats three times at intervals of two weeks. The vaccine was shown to lower the blood pressure of the rats for up to six months and to reduce tissue damage to the heart and blood arteries, both of which are linked to high blood pressure.

There were no additional indicators of organ failure, such as the kidneys or liver, that the experts discovered. Other trials have investigated the use of vaccines to treat hypertension, but none have yielded long-lasting improvements, and some have revealed negative side effects.

Reduced blood pressure, even in the case of mild hypertension, has the potential to save your life. Hypertension is the single most important factor in early mortality. Even if your hypertension is only slightly elevated, evidence suggests that medication treatment can boost your chances of living a longer life.

Remember the last time you got your blood pressure taken? Probably never. High blood pressure, also known as hypertension, is the leading cause of death before the age of 65. Hypertension affects one in every three people in the United States. The illness affects two out of every three Americans over the age of 65.

According to a recent report released in the Archives of Internal Medicine, especially if you only have mild hypertension, or stage 1, medication can reduce overall your risk of mortality.

Blood pressure can be measured in millimetres ( mm (bpm), which is an abbreviation. Mercury is represented by the scientific sign Hg.

“A modest average blood pressure reduction of 3.6/2.4 mm Hg was associated with significant reductions in stroke, cardiovascular deaths, and total deaths,” said Dr. Jackson T. Wright, Jr., Ph.D., of Case Western Reserve University in Cleveland, Ohio, in an editorial published alongside the study. Reduced blood pressure is related with improved cardiovascular outcomes across all age groups, including those in the lower range.

Leave a Reply

Your email address will not be published.